Group 1 - The core viewpoint of the articles highlights the trend of public fund companies in China investing their own funds into their equity funds, reflecting confidence in the long-term stability and health of the capital market [1][2] - Both Bosera Fund Management and Dongfanghong Asset Management announced plans to invest 10 million yuan each into their respective equity funds, signaling a commitment to aligning interests with investors [1] - The self-purchase behavior of public fund companies is seen as a significant measure to enhance investor confidence, with over 260 instances of self-purchases recorded this year, resulting in a net subscription amount of 1.885 billion yuan for equity funds [1] Group 2 - In the self-purchase of stock funds, index products dominate, accounting for approximately 80% of the total net subscription amount, with passive index and enhanced index funds attracting 725 million yuan and 91 million yuan respectively [2] - Among the 70 public institutions that self-purchased equity products this year, 50 had net subscription amounts exceeding 50 million yuan, with ICBC Credit Suisse Fund leading at 397 million yuan [2] - The recent regulatory framework introduced by the China Securities Regulatory Commission emphasizes the importance of self-purchases and long-term performance metrics, encouraging more fund companies to invest their own capital [2]

Group 1 - The Hong Kong IPO market shows a significant recovery in profitability, with only 7 out of 27 companies experiencing a first-day drop, resulting in a break rate of 25.93%, the lowest since 2017 [1] - Notable performances include Yimeng Biotech and Mixue Group, which saw first-day increases of 116.7% and 43.21% respectively [1] - The overall low valuation in Hong Kong is attracting overseas capital, supported by Chinese policies promoting innovation and capital market development [1] Group 2 - The enterprise-grade SSD market in China is projected to reach $6.25 billion in 2024, reflecting a year-on-year growth of 187.9% [2] - Solidigm and Samsung hold the largest market shares, with Samsung facing domestic competition and cost pressures [2] - The demand for SSDs is driven by increased investments in AI by cloud computing and internet companies, as well as the modernization of digital infrastructure [2] Group 3 - In Sichuan, over 810,000 units of home appliances and digital products have been replaced under the old-for-new policy, generating a consumption boost of 25.4 billion yuan [3] - Air conditioners are the most popular items in the replacement program, accounting for 40.42% of total sales [3] - The policy is effectively stimulating market demand and promoting local production capacity expansion [3] Group 4 - ByteDance plans to ban third-party AI development software to mitigate data leak risks, replacing it with its in-house tool Trae [4] - The FTC's antitrust case against Meta has concluded, with a ruling expected within four months that could lead to the divestiture of Instagram and WhatsApp [4] Group 5 - ExxonMobil is in exclusive negotiations to sell its majority stake in its French subsidiary Esso to North Atlantic, with a sale price of €149.19 per share [5] - The sale is expected to be completed in the last quarter of this year [5] Group 6 - Dajiang is reportedly entering the robotic vacuum market, with its first product expected to launch in June [6] - Longfeng Pharmaceutical's IPO application has expired after six months without progress [6] Group 7 - Diguang Robot has completed a $100 million Series A financing round, attracting investment from several prominent institutions [7] - China Energy Construction has won a significant coal-fired power project worth approximately 14.586 billion yuan [7] Group 8 - Taiji Industry plans to repurchase shares worth between 1 billion and 1.2 billion yuan, with a maximum repurchase price of 10.38 yuan per share [8] Group 9 - Dalian Electric Porcelain is a recommended candidate for a 290 million yuan project with the State Grid, which would account for 19.38% of its 2024 revenue [9] Group 10 - Fuda Co. is set to invest in a new precision gear project for electric drive systems in new energy vehicles, with plans to use self-funding and financing [10] Group 11 - The Shanghai Composite Index experienced slight fluctuations, with new consumption stocks performing well despite overall market declines [11] - Beverage manufacturing and nuclear power stocks saw significant gains, while pharmaceutical stocks faced corrections [11]

Group 1 - The A-share and Hong Kong stock indices collectively declined on May 28, with the Hang Seng-Hushen Hong Kong Innovative Drug Selected 50 Index experiencing a slight pullback [1] - The Tianhong Innovative Drug ETF (517380) showed fluctuating performance, with a premium rate of 0.33% as of the report, and several constituent stocks such as Ganli Pharmaceutical and Heng Rui Medicine saw gains [1] - As of May 27, the Hang Seng-Hushen Hong Kong Innovative Drug Selected 50 Index has increased by 15.61% since the beginning of the year [1] Group 2 - Pacific Securities emphasizes the importance of the pharmaceutical sector due to changes in market pricing power and suggests a strategic focus on AI healthcare and innovative drugs [2] - Guotai Junan Securities notes that several domestic innovative drug research projects have been selected for the 2025 ASCO conference, indicating a robust trend in domestic pharmaceutical R&D, particularly in cancer treatment [2]

Group 1 - The pilot program for credit bond ETFs to conduct general pledge-style repurchase transactions is set to be officially implemented soon, marking a new phase in liquidity management tools in China's bond market [2] - The inclusion of credit bond ETFs in the general repurchase pledge library reflects support for green bonds, sci-tech innovation bonds, and corporate bonds from private enterprises, signaling a commitment to market construction for credit bond ETFs [2] - The current environment of "asset scarcity" is slowing down, with credit bonds expected to outperform interest rate bonds in a defensive strategy, emphasizing the importance of duration selection in different stages [2] Group 2 - As of May 28, 2025, the Tianhong credit bond ETF (159398) showed active trading with a turnover rate of 91.29% and a transaction volume of 5.1 billion yuan, indicating strong market activity [3] - The Tianhong credit bond ETF reached a new high in scale at 5.673 billion yuan and a new high in shares at 56.3323 million, reflecting growing investor interest [3] - The fund has seen continuous net inflows over the past six days, totaling 1.325 billion yuan, with an average daily net inflow of 221 million yuan [3] Group 3 - The management fee for the Tianhong credit bond ETF is 0.15%, and the custody fee is 0.05%, which are the lowest among comparable funds [4] - The tracking error for the Tianhong credit bond ETF over the past month is 0.006%, indicating the highest tracking precision among comparable funds [4] - The top ten weighted stocks in the Shenzhen benchmark market-making credit bond index account for 8.59% of the index, reflecting the concentration of holdings [4]

21世纪经济报道特约记者 庞华玮 广州报道 首批26只新模式浮动费率基金落地。 这批新版本的浮动费率基金开启同台竞争模式。 要卖产品，最好用的就是基金经理的标签。对此，不少基金公司表示，将派出旗下长期业绩表现较好的基金经理来管理浮动费 率产品，全力做好产品业绩，切实为投资者创造回报。 而从他们派出基金经理的风格和业绩，或可以看出各家对浮动费率产品的定位和预期。 来盘点一下，26只浮动费率基金，谁是你喜欢的基金经理？ 业绩为王 26只浮动费率基金同台竞技，最大卖点是基金经理。 不过，这次浮动费率基金产品，除了招商基金的朱红裕、东方红资管的周云、景顺长城的农冰立、博时的田俊维等人，不少基 金经理的名气不算很响。比如华商基金的张明昕，此前在申万宏源证券和英大资产做投资，今年才转入公募行业。 但据21世纪经济报道记者发现，大部分基金公司都派出了过往长期业绩较好的基金经理。 特别是部分基金公司派出了当家选手。 比如华夏基金派出了王君正，他曾和鄢耀一起管理工银金融地产混合，并在2014年时夺得了当年的公募冠军，长期业绩稳定。 他去年9月离开工银瑞信基金，加盟华夏基金。 东方红资管派出了周云，在所有基金经理中有最长投资经理 ...

Core Insights - The total trading volume of non-monetary ETFs reached 189.758 billion, with 46 ETFs exceeding 1 billion in trading volume [1] - The Short-term Bond ETF, Policy Financial Bond ETF, and Credit Bond ETF led the market in trading volume, with respective volumes of 11.604 billion, 9.207 billion, and 8.669 billion [1] - The S&P 500 ETF, Benchmark Treasury ETF, and 5-Year Local Government Bond ETF had the highest turnover rates, at 466.27%, 357.32%, and 237.37% respectively [1] Trading Volume Summary - The Short-term Bond ETF (511360.SH) had a trading volume of 11.604 billion, with a recent increase of 92.43% compared to the previous trading day [1] - The Policy Financial Bond ETF (511520.SH) recorded a trading volume of 9.207 billion, with a recent average trading volume of 9.658 billion over the past 5 days [2] - The Credit Bond ETF (159395.SZ) had a trading volume of 8.669 billion, with a significant increase in trading activity [5] Turnover Rate Summary - The S&P 500 ETF (159612.SZ) had a turnover rate of 466.27%, indicating high trading activity [7] - The Benchmark Treasury ETF (511100.SH) and 5-Year Local Government Bond ETF (511060.SH) followed with turnover rates of 357.32% and 237.37% respectively [7] Sector Performance - The Information Technology ETF and Hong Kong Innovative Drug ETFs had the highest volatility, with fluctuations of 4.35% and 4.35% respectively [8] - The Hong Kong Innovative Drug ETF (159570.SZ) had a trading volume of 2.715 billion, reflecting strong market interest [8] - The Hong Kong Innovative Drug ETF (513120.SH) had a trading volume of 10.022 billion, indicating robust trading activity [9] Recent Performance - The Short-term Bond ETF saw a price increase of 0.01% today, with a 5-day and 20-day increase of 0.01% and 0.16% respectively [1] - The Policy Financial Bond ETF experienced a slight decline of 0.12%, but had a 5-day and 20-day increase of 0.16% and 0.31% respectively [2] - The Hong Kong Innovative Drug ETF (159570.SZ) increased by 3.88% today, with a 5-day increase of 3.10% [8]

Core Viewpoint - The launch of the first batch of 26 new floating rate funds marks a significant innovation in the fund management industry, with a focus on aligning the interests of fund managers and investors through a unique fee structure [3][4]. Fund Launch Details - The new floating rate funds were registered by the China Securities Regulatory Commission on May 23, just a week after their application on May 16, indicating a rapid registration process [3]. - Major fund companies involved include E Fund, Huaxia Fund, and others, with most products being mixed funds, except for one stock fund from Bosera Fund [4]. - The subscription period for these funds began on May 27 and will generally end in mid-June [4]. Fee Structure - The management fee structure is innovative: a flat rate of 1.2% is charged if the investment period is less than one year. For periods longer than one year, fees are tiered at 1.2%, 1.5%, and 0.6% based on performance relative to benchmarks [3][7]. - If the annualized excess return exceeds 6% and the holding return is positive, the management fee is 1.5%. Conversely, if the annualized excess return is -3% or lower, the fee drops to 0.6% [7]. Performance Metrics - Among the 16 funds, 17 fund managers are involved, with 15 achieving positive annualized returns. The best performer is Wang Mingxu from GF Fund [7]. - Historical data shows that over 37% of floating rate funds have negative returns since inception, with 14 funds losing over 40% [9][11]. Fund Performance Comparison - The performance of existing floating rate funds varies significantly, with some achieving returns over 200% since inception, while others have seen losses exceeding 40% [10][11]. - Only 36% of the analyzed floating rate funds have annualized returns that outperform their benchmarks [11].

01 基金经理最新动态 1.民生加银基金朱永明新任副总经理 5月27日，民生加银基金发布公告，原董事会秘书朱永明于5月26日新任副总经理，丁辉新任董事会秘书。 2. 姚艺：长期看好创新药的成长空间 宝盈基金经理姚艺近日接受采访时表示，看好创新药板块未来的投资机会，并建议投资者以更长视角看待这一领域的投资价值。创新药企业业绩正在兑 现，以及海外市场拓展将驱动股价持续增长，长期看好创新药的成长空间。 不过，今年以来创新药个股已有较高幅度反弹，姚艺也提醒道，任何板块短期涨多了都会调整，创新药板块经历过3到4个月的累积上涨后，短期可能出现 技术性调整，但行业的基本面趋势并未改变，产业趋势的加速才刚刚开始，调整期恰是布局板块的好机会。 02 今日基金新闻速览 1. 又有代销机构被多家基金公司取消合作 5月27日，多家基金公司公告称，终止民商基金销售（上海）有限公司办理对应公司旗下基金相关业务。据统计，目前已有东吴、银华、华泰柏瑞、德邦 等多家基金公司与之终止或即将终止合作。 2. 5月以来超80只基金提示溢价风险 近期，跨境ETF高溢价现象频繁出现。Wind统计数据显示，5月份以来，已有超80只基金发布溢价风险提示公告 ...

Group 1 - The core viewpoint is that the innovative drug sector is experiencing a significant recovery in stock prices, attracting attention from brokers for research and investment opportunities [2] - The Tianhong Innovative Drug ETF (517380) has seen a net inflow of 3.6 million yuan, with a current scale of 389 million yuan as of May 26 [1] - The Tianhong ETF is the only product that comprehensively covers the innovative drug sector across A-shares and Hong Kong stocks, with a focus on the "Hengsheng Huasheng Hong Kong Innovative Drug Selected 50" index [1] Group 2 - The innovative drug industry is entering a new cycle of value reassessment due to a combination of policy, industry, and performance factors [2] - Longjiang Securities suggests that the previous valuation methods used during the bear market may no longer be applicable, indicating a need for a re-evaluation of the valuation system for innovative drug companies [2] - There has been significant interest from brokers, with nearly 60 companies in the pharmaceutical and biotechnology sector being researched this month, highlighting the sector's attractiveness [2]

Group 1 - The core viewpoint of the news highlights the resilience of the banking sector, as evidenced by the rise of the China Securities Banking Index despite a general market downturn [1] - The banking ETF Tianhong (515290) has seen a net inflow of 155 million yuan over the past four trading days, indicating strong investor interest [1] - Major state-owned banks have collectively lowered interest rates, with one-year fixed deposit rates falling below 1% for the first time, which may impact the overall banking landscape [1] Group 2 - Open Source Securities anticipates a recovery in credit in May and June, with annual loan growth expected to remain stable [2] - Pacific Securities notes that the implementation of incremental policies is likely to stabilize market expectations, enhancing the attractiveness of the banking sector as a dividend asset [2] - The banking sector is expected to see steady growth in revenue and net profit, with a focus on stable dividend strategies [2]